Building category-defining healthcare companies at the inflection point of growth.
Totipotent Capital backs early growth-stage healthcare and life sciences companies with demonstrated traction, investing just before meaningful scale. Our portfolio reflects a disciplined, thesis-driven approach informed by deep clinical, operational, and regulatory expertise.
Selected Portfolio
Investment
Antiverse
Antiverse
Live Site
Fuse Oncology
Fuse Oncology
Live Site

Agile Devices
Agile Devices
Live Site

Joylux
Joylux
Live Site

Peptinovo Biopharma
Peptinovo Biopharma
Live Site

Elitone
Elitone
Live Site

Smileyscope
Smileyscope
Live Site

Wavely Diagnostics
Wavely Diagnostics
Live Site

Wellsheet
Wellsheet
Live Site

Midstream Health
Midstream Health
Live Site

Embr Labs
Embr Labs
Live Site

Biorithm
Biorithm
Live Site
What We Look For
Demonstrated Traction
Commercial validation through customer adoption, revenue growth, clinical outcomes, or strategic partnerships.
Clear Path to Scale
Businesses positioned for repeatable growth through scalable execution, operational leverage, and disciplined economics.
Healthcare System Alignment
Solutions designed to integrate within clinical workflows, reimbursement models, regulatory frameworks, and evolving models of care.
Differentiated Advantage
Technology, data, or market positioning that creates durable competitive advantage and long-term strategic value.
Exceptional Teams
Founders with deep domain expertise, operational discipline, and the ability to navigate complex healthcare environments.
Inflection Point Opportunity
Companies entering a stage where traction, timing, and operational readiness converge to accelerate growth and reduce risk.
